Number | Cited Articles |
1 |
Michelle J. Nyhan, Tracey R. O’Donovan, Antonius W. M. Boersma, Erik A. C. Wiemer, Sharon L. McKenna. MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2123-6
|
2 |
Preethi Krishnan, Sunita Ghosh, Bo Wang, Dongping Li, Ashok Narasimhan, Richard Berendt, Kathryn Graham, John R. Mackey, Olga Kovalchuk, Sambasivarao Damaraju. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. BMC Genomics 2015; 16(1) doi: 10.1186/s12864-015-1899-0
|
3 |
Mohammadreza Bazavar, Jafar Fazli, Amir Valizadeh, Binfang Ma, Erfan Mohammadi, Zatollah Asemi, Forough Alemi, Masoomeh Maleki, Shilong Xing, Bahman Yousefi. miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells. Pathology - Research and Practice 2020; 216(11): 153176 doi: 10.1016/j.prp.2020.153176
|
4 |
Ning Wang, Chen Zhu, Ye Xu, Wenliang Qian, Min Zheng. Negative Regulation of PTEN by MicroRNA-221 and Its Association with Drug Resistance and Cellular Senescence in Lung Cancer Cells. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/7908950
|
5 |
David Vrana, Viktor Hlavac, Veronika Brynychova, Radka Vaclavikova, Cestmir Neoral, Jiri Vrba, Rene Aujesky, Marcel Matzenauer, Bohuslav Melichar, Pavel Soucek. ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer. International Journal of Molecular Sciences 2018; 19(3): 868 doi: 10.3390/ijms19030868
|
6 |
Andrea Ritter, Marc Hirschfeld, Kai Berner, Gerta R�cker, Markus J�ger, Daniela Weiss, Markus Medl, Claudia N�thling, Sandra Gassner, Jasmin Asberger, Thalia Erbes. Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4920
|
7 |
Wanli Yang, Jiaojiao Ma, Wei Zhou, Xin Zhou, Bo Cao, Hongwei Zhang, Qingchuan Zhao, Daiming Fan, Liu Hong. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer. Expert Review of Gastroenterology & Hepatology 2017; 11(12): 1151 doi: 10.1080/17474124.2017.1372189
|
8 |
Wenzhi Liu, Mengkao Li, Xiangming Chen, Shan Zhu, Hailong Shi, Dawei Zhang, Cheng Cheng, Baosheng Li. MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-23421-3
|
9 |
Yan Wang, Yue Zhao, Andreas Herbst, Thomas Kalinski, Jiwei Qin, Xiaoyan Wang, Zhenzhong Jiang, Frank Benedix, Sabine Franke, Thomas Wartman, Peter Camaj, Walter Halangk, Frank T. Kolligs, Karl W. Jauch, Peter J. Nelson, Christiane J. Bruns. miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression. Annals of Surgery 2016; 264(5): 804 doi: 10.1097/SLA.0000000000001928
|
10 |
Tomoyuki Okumura, Hirohumi Kojima, Takeshi Miwa, Shinichi Sekine, Isaya Hashimoto, Shozo Hojo, Takuya Nagata, Yutaka Shimada. The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0985-3
|
11 |
Ying-ying Jin, Qing-juan Chen, Kun Xu, Hong-tao Ren, Xing Bao, Yi-nan Ma, Yang Wei, Hong bing Ma. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN. Molecular and Cellular Biochemistry 2016; 422(1-2): 161 doi: 10.1007/s11010-016-2816-9
|
12 |
Ye Sol Kim, Sae Jeong Park, Yeon Seon Lee, Hyun Kyung Kong, Jong Hoon Park. miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer. Oncotarget 2106; 7(27): 42261 doi: 10.18632/oncotarget.9950
|
13 |
Wen-Tao Wang, Chang-Qing Guo, Guang-Hui Cui, Song Zhao. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma. World Journal of Gastroenterology 2019; 25(37): 5604-5618 doi: 10.3748/wjg.v25.i37.5604
|
14 |
Li Li, Haifeng Zhang, Xiaolong Wang, Jiali Wang, Haitao Wei. Long non-coding RNA CASC2 enhanced cisplatin-induced viability inhibition of non-small cell lung cancer cells by regulating the PTEN/PI3K/Akt pathway through down-regulation of miR-18a and miR-21. RSC Advances 2018; 8(29): 15923 doi: 10.1039/C8RA00549D
|
15 |
Masato Hayashi, Hirofumi Kawakubo, Kazumasa Fukuda, Shuhei Mayanagi, Rieko Nakamura, Koichi Suda, Testu Hayashida, Norihito Wada, Yuko Kitagawa.
THUMP domain containing 2 protein possibly induces resistance to cisplatin and 5‐fluorouracil in
in vitro
human esophageal squamous cell carcinoma cells as revealed by transposon activation mutagenesis
. The Journal of Gene Medicine 2019; 21(12) doi: 10.1002/jgm.3135
|
16 |
Chen Zi, Dexin Zeng, Jiyong Zhou, Jianjun Dai, Luyan Jiang, Feng Xue, Yuan Jiang, Baoguang Li. Selected microRNA-192 mutant indicates association with several function genes in bovine cells. Genes & Genomics 2018; 40(4): 361 doi: 10.1007/s13258-017-0635-3
|
17 |
Amy Buckley, Becky Bibby, Margaret Dunne, Susan Kennedy, Maria Davern, Breandán Kennedy, Stephen Maher, Jacintha O’Sullivan. Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells. Pharmaceuticals 2019; 12(1): 33 doi: 10.3390/ph12010033
|
18 |
Christina Just, Juliana Knief, Pamela Lazar-Karsten, Ekaterina Petrova, Richard Hummel, Christoph Röcken, Ulrich Wellner, Christoph Thorns. MicroRNAs as Potential Biomarkers for Chemoresistance in Adenocarcinomas of the Esophagogastric Junction. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/4903152
|
19 |
Soudeh Ghafouri‐Fard, Hamed Shoorei, Sepideh Dashti, Wojciech Branicki, Mohammad Taheri. Expression profile of lncRNAs and miRNAs in esophageal cancer: Implications in diagnosis, prognosis, and therapeutic response. Journal of Cellular Physiology 2020; 235(12): 9269 doi: 10.1002/jcp.29825
|
20 |
Tomasz Kolenda, Kacper Guglas, Magda Kopczyńska, Joanna Sobocińska, Anna Teresiak, Renata Bliźniak, Katarzyna Lamperska. Good or not good: Role of miR-18a in cancer biology. Reports of Practical Oncology & Radiotherapy 2020; 25(5): 808 doi: 10.1016/j.rpor.2020.07.006
|
21 |
Tomasz Kolenda, Anna Teresiak, Marta Kapałczyńska, Weronika Przybyła, Maria Zajączkowska, Renata Bliźniak, Katarzyna Lamperska. let-7d i miR-18a jako biomarkery w nowotworach głowy i szyi. Zeszyty Naukowe WCO, Letters in Oncology Science 2015; 12(3): 37 doi: 10.1016/j.onko.2015.08.001
|
22 |
Hong Yu, Jianying Sun, Shaochang Jiang, Ying Xu. MicroRNA‑490‑3p regulates cell proliferation and apoptosis in gastric cancer via direct targeting of AKT1. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.7042
|
23 |
Kai Wu, Yamei Hu, Kanglu Yan, Yu Qi, Chunyang Zhang, Dengyan Zhu, Donglei Liu, Song Zhao. microRNA‐10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer. Journal of Cellular Physiology 2020; 235(2): 1247 doi: 10.1002/jcp.29040
|
24 |
A. K. Eichelmann, C. Matuszcak, K. Lindner, J. Haier, D. J. Hussey, R. Hummel. Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-35799-1
|
25 |
Christine Kestens, Peter D Siersema, Jantine WPM van Baal. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer. World Journal of Gastroenterology 2016; 22(1): 1-7 doi: 10.3748/wjg.v22.i1.1
|
26 |
Naixin Ding, Xiujin Sun, Tingting Wang, Lei Huang, Jing Wen, Yiqin Zhou. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3639
|
27 |
Bernhard Biersack. Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs. Non-coding RNA Research 2017; 2(1): 1 doi: 10.1016/j.ncrna.2016.10.001
|
28 |
Patrick Sven Plum, Ute Warnecke-Eberz, Uta Drebber, Seung-Hun Chon, Hakan Alakus, Arnulf Heinrich Hölscher, Alexander Quaas, Christiane Josephine Bruns, Ines Gockel, Dietmar Lorenz, Ralf Metzger, Elfriede Bollschweiler. Upregulation of miR-17-92 cluster is associated with progression and lymph node metastasis in oesophageal adenocarcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-48624-0
|
29 |
Weiguo Zhang, Caipeng Lei, Junli Fan, Jing Wang. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis. Biochemical and Biophysical Research Communications 2016; 477(1): 144 doi: 10.1016/j.bbrc.2016.06.034
|
30 |
Changlin Zhou, Lin Zhang, Peng Xu. Growth inhibition and chemo‑radiosensitization of esophageal squamous cell carcinoma by survivin‑shRNA lentivirus transfection. Oncology Letters 2018; doi: 10.3892/ol.2018.9280
|
31 |
Min Kang, Yan Li, Shengtao Zhu, Shutian Zhang, Shuilong Guo, Peng Li. MicroRNA‑193b acts as a tumor suppressor gene in human esophageal squamous cell carcinoma via target regulation of KRAS. Oncology Letters 2019; doi: 10.3892/ol.2019.10039
|
32 |
Song Yang, Peng Wang, Songhua Wang, Aihua Cong, Qi Zhang, Wenhao Shen, Xiangyi Li, Wei Zhang, Gaohua Han. <p>miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB</p>. Cancer Management and Research 2020; : 4981 doi: 10.2147/CMAR.S251264
|
33 |
Jie Ma, Yanli Lin, Min Zhan, Dean L Mann, Sanford A Stass, Feng Jiang. Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer. Laboratory Investigation 2015; 95(10): 1197 doi: 10.1038/labinvest.2015.88
|
34 |
Yury O. Nunez Lopez, Berta Victoria, Pawel Golusinski, Wojciech Golusinski, Michal M. Masternak. Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes. Reports of Practical Oncology & Radiotherapy 2018; 23(1): 6 doi: 10.1016/j.rpor.2017.10.003
|
35 |
Chia-Wei Lin, Ming-Shiou Jan, Jung-Hua Steven Kuo. The microRNA expression profiles in extracellular vesicles from HeLa cancer cells in response to cationic lipid- or polyethylenimine-mediated gene delivery. Journal of Drug Targeting 2019; 27(1): 94 doi: 10.1080/1061186X.2018.1491977
|
36 |
Tian-Liang Zheng, De-Ping Li, Zhan-Feng He, Song Zhao. miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0943-6
|
37 |
Cheng-Han Lin, Chen-Hsun Tsai, Ching-Tung Yeh, Jui-Lin Liang, Wan-Chun Hung, Forn-Chia Lin, Wei-Lun Chang, Hao-Yi Li, Yun-Chin Yao, Tai-I Hsu, Yu-Cheng Lee, Yi-Ching Wang, Bor-Shyang Sheu, Wu-Wei Lai, Marcus J. Calkins, Michael Hsiao, Pei-Jung Lu. MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma. Oncotarget 2016; 7(26): 39680 doi: 10.18632/oncotarget.9444
|
38 |
Kirsten Lindner, Ann-Kathrin Eichelmann, Christiane Matuszcak, Damian Hussey, Jörg Haier, Richard Hummel. Complex Epigenetic Regulation of Chemotherapy Resistance and Biology in Esophageal Squamous Cell Carcinoma via MicroRNAs. International Journal of Molecular Sciences 2018; 19(2): 499 doi: 10.3390/ijms19020499
|
39 |
Baerxiaguli Zabihula, Mukedaisi Yiliyasi, Yanrong Lu, Adili Salai. MicroRNA‑490‑3p inhibits proliferation and stimulates apoptosis of ESCC cells via MAPK1 downregulation. Oncology Letters 2019; doi: 10.3892/ol.2019.10636
|
40 |
Chi Zhang, Qunfeng Ma, Yinan Shi, Xue Li, Ming Wang, Junfeng Wang, Jianlin Ge, Zhinan Chen, Ziling Wang, Hong Jiang. A novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cell line Eca-109/5-FU with significant drug resistance-related characteristics. Oncology Reports 2017; 37(5): 2942 doi: 10.3892/or.2017.5539
|
41 |
Christiane Matuszcak, Kirsten Lindner, Ann-Kathrin Eichelmann, Damian J. Hussey, Jörg Haier, Richard Hummel. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma. Surgical Oncology 2018; 27(3): 392 doi: 10.1016/j.suronc.2018.04.001
|